These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 10928474

  • 1. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly.
    Mikkelsson J, Perola M, Wartiovaara U, Peltonen L, Palotie A, Penttilä A, Karhunen PJ.
    Thromb Haemost; 2000 Jul; 84(1):78-82. PubMed ID: 10928474
    [Abstract] [Full Text] [Related]

  • 2. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction.
    Doggen CJ, Bertina RM, Cats VM, Reitsma PH, Rosendaal FR.
    Thromb Haemost; 1999 Jul; 82(1):115-20. PubMed ID: 10456464
    [Abstract] [Full Text] [Related]

  • 3. The 4G4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphism is associated with coronary atherosclerosis in patients at high risk for this disease.
    Gardemann A, Lohre J, Katz N, Tillmanns H, Hehrlein FW, Haberbosch W.
    Thromb Haemost; 1999 Sep; 82(3):1121-6. PubMed ID: 10494775
    [Abstract] [Full Text] [Related]

  • 4. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM.
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [Abstract] [Full Text] [Related]

  • 5. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde.
    Ye S, Green FR, Scarabin PY, Nicaud V, Bara L, Dawson SJ, Humphries SE, Evans A, Luc G, Cambou JP.
    Thromb Haemost; 1995 Sep; 74(3):837-41. PubMed ID: 8571307
    [Abstract] [Full Text] [Related]

  • 6. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.
    Matsubara Y, Murata M, Isshiki I, Watanabe R, Zama T, Watanabe G, Watanabe K, Ikeda Y.
    Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442
    [Abstract] [Full Text] [Related]

  • 7. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.
    Fu L, Jin H, Song K, Zhang C, Shen J, Huang Y.
    Chin Med J (Engl); 2001 Mar; 114(3):266-9. PubMed ID: 11780311
    [Abstract] [Full Text] [Related]

  • 8. Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease.
    Grancha S, Estellés A, Tormo G, Falco C, Gilabert J, España F, Cano A, Segui R, Aznar J.
    Thromb Haemost; 1999 Apr; 81(4):516-21. PubMed ID: 10235431
    [Abstract] [Full Text] [Related]

  • 9. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E, Deitcher SR, Cicek M, Liu X, Plummer S, Casey G, Witte JS.
    Prostate; 2007 Feb 01; 67(2):172-7. PubMed ID: 17044080
    [Abstract] [Full Text] [Related]

  • 10. PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample.
    Meigs JB, Dupuis J, Liu C, O'Donnell CJ, Fox CS, Kathiresan S, Gabriel SB, Larson MG, Yang Q, Herbert AG, Wilson PW, Feng D, Tofler GH, Cupples LA.
    Obesity (Silver Spring); 2006 May 01; 14(5):753-8. PubMed ID: 16855181
    [Abstract] [Full Text] [Related]

  • 11. A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency.
    Zöller B, García de Frutos P, Dahlbäck B.
    Thromb Haemost; 1998 Apr 01; 79(4):802-7. PubMed ID: 9569196
    [Abstract] [Full Text] [Related]

  • 12. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.
    Pérez-Martínez P, Adarraga-Cansino MD, Fernández de la Puebla RA, Blanco-Molina A, Delgado-Lista J, Marín C, Ordovás JM, López-Miranda J, Pérez-Jiménez F.
    Br J Nutr; 2008 Apr 01; 99(4):699-702. PubMed ID: 17903340
    [Abstract] [Full Text] [Related]

  • 13. Association of the endothelial nitric oxide synthase gene polymorphism with risk of coronary artery disease and myocardial infarction in middle-aged men.
    Kunnas TA, Ilveskoski E, Niskakangas T, Laippala P, Kajander OA, Mikkelsson J, Goebeler S, Penttilä A, Perola M, Nikkari ST, Karhunen PJ.
    J Mol Med (Berl); 2002 Sep 01; 80(9):605-9. PubMed ID: 12226742
    [Abstract] [Full Text] [Related]

  • 14. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis.
    Akhter MS, Biswas A, Ranjan R, Meena A, Yadav BK, Sharma A, Saxena R.
    Clin Appl Thromb Hemost; 2010 Apr 01; 16(2):184-8. PubMed ID: 19419975
    [Abstract] [Full Text] [Related]

  • 15. The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia.
    Yamada N, Arinami T, Yamakawa-Kobayashi K, Watanabe H, Sohda S, Hamada H, Kubo T, Hamaguchi H.
    J Hum Genet; 2000 Apr 01; 45(3):138-41. PubMed ID: 10807538
    [Abstract] [Full Text] [Related]

  • 16. 4G/5G polymorphism and haplotypes of SERPINE1 in atherosclerotic diseases of coronary arteries.
    Koch W, Schrempf M, Erl A, Mueller JC, Hoppmann P, Schömig A, Kastrati A.
    Thromb Haemost; 2010 Jun 01; 103(6):1170-80. PubMed ID: 20352162
    [Abstract] [Full Text] [Related]

  • 17. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
    Castelló R, España F, Vázquez C, Fuster C, Almenar SM, Aznar J, Estellés A.
    Thromb Res; 2006 Jun 01; 117(5):487-92. PubMed ID: 15907980
    [Abstract] [Full Text] [Related]

  • 18. PAI-1 4G/5G gene polymorphism is associated with angiographic patency in ST-elevation myocardial infarction patients treated with thrombolytic therapy.
    Ozkan B, Cagliyan CE, Elbasan Z, Uysal OK, Kalkan GY, Bozkurt M, Tekin K, Bozdogan ST, Ozalp O, Duran M, Sahin DY, Cayli M.
    Coron Artery Dis; 2012 Sep 01; 23(6):400-3. PubMed ID: 22850480
    [Abstract] [Full Text] [Related]

  • 19. Plasminogen activator inhibitor-1 polymorphism (4G/5G) predicts recurrence in nonhyperlipidemic postinfarction patients.
    Corsetti JP, Ryan D, Moss AJ, Rainwater DL, Zareba W, Sparks CE.
    Arterioscler Thromb Vasc Biol; 2008 Mar 01; 28(3):548-54. PubMed ID: 18096824
    [Abstract] [Full Text] [Related]

  • 20. An effect of the PAI-1 4G/5G polymorphism on cholesterol levels may explain conflicting associations with myocardial infarction and stroke.
    Boncoraglio GB, Bodini A, Brambilla C, Carriero MR, Ciusani E, Parati EA.
    Cerebrovasc Dis; 2006 Mar 01; 22(2-3):191-5. PubMed ID: 16735791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.